M. Witzenrath, A. Vlaar, M. Bauer, D. Annane, L. Heunks, B. Mourvillier, L. Hercilla Vásquez, T. Welte, P. van Paassen, S. de Bruin, E. Lim, M. Brouwer, P. Tuinman, J. Saraiva, G. Marx, S. Lobo, R. Boldo, J. Simón-Campos, A. Cornet, A. Grebenyuk, J. Engelbrecht, M. Habel, C. Thielert, J. Dickinson, S. Rückinger, R. Zerbib, D. Neukirchen, K. Pilz, R. Guo, D. van de Beek, N. Riedemann, The PANAMO Study Group
{"title":"抗c5a维罗莫单抗降低COVID-19危重患者和严重ARDS患者的全因死亡率:一项3期随机双盲、安慰剂对照研究","authors":"M. Witzenrath, A. Vlaar, M. Bauer, D. Annane, L. Heunks, B. Mourvillier, L. Hercilla Vásquez, T. Welte, P. van Paassen, S. de Bruin, E. Lim, M. Brouwer, P. Tuinman, J. Saraiva, G. Marx, S. Lobo, R. Boldo, J. Simón-Campos, A. Cornet, A. Grebenyuk, J. Engelbrecht, M. Habel, C. Thielert, J. Dickinson, S. Rückinger, R. Zerbib, D. Neukirchen, K. Pilz, R. Guo, D. van de Beek, N. Riedemann, The PANAMO Study Group","doi":"10.1164/ajrccm-conference.2023.207.1_meetingabstracts.a6237","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":242992,"journal":{"name":"D16. ADVANCING THE SCIENCE OF ARDS AND ACUTE RESPIRATORY FAILURE","volume":"97 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2023-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Anti-C5a Vilobelimab Reduces All-cause Mortality in Critically Ill COVID-19 Patients and in Those With Severe ARDS: A Phase 3 Randomized Double-blind, Placebo-controlled Study\",\"authors\":\"M. Witzenrath, A. Vlaar, M. Bauer, D. Annane, L. Heunks, B. Mourvillier, L. Hercilla Vásquez, T. Welte, P. van Paassen, S. de Bruin, E. Lim, M. Brouwer, P. Tuinman, J. Saraiva, G. Marx, S. Lobo, R. Boldo, J. Simón-Campos, A. Cornet, A. Grebenyuk, J. Engelbrecht, M. Habel, C. Thielert, J. Dickinson, S. Rückinger, R. Zerbib, D. Neukirchen, K. Pilz, R. Guo, D. van de Beek, N. Riedemann, The PANAMO Study Group\",\"doi\":\"10.1164/ajrccm-conference.2023.207.1_meetingabstracts.a6237\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":242992,\"journal\":{\"name\":\"D16. ADVANCING THE SCIENCE OF ARDS AND ACUTE RESPIRATORY FAILURE\",\"volume\":\"97 1\",\"pages\":\"0\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2023-05-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"D16. ADVANCING THE SCIENCE OF ARDS AND ACUTE RESPIRATORY FAILURE\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1164/ajrccm-conference.2023.207.1_meetingabstracts.a6237\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"D16. ADVANCING THE SCIENCE OF ARDS AND ACUTE RESPIRATORY FAILURE","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1164/ajrccm-conference.2023.207.1_meetingabstracts.a6237","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Anti-C5a Vilobelimab Reduces All-cause Mortality in Critically Ill COVID-19 Patients and in Those With Severe ARDS: A Phase 3 Randomized Double-blind, Placebo-controlled Study